HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
about
The significance of markers in the diagnosis of endometrial cancerSurgical management of early endometrial cancer: an update and proposal of a therapeutic algorithmSparse feature selection for classification and prediction of metastasis in endometrial cancer.ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.Assessment of levels of the tumor markers HE4 and CA125 considering staging, grading and histological types of endometrial cancer.Current status of molecular biomarkers in endometrial cancer.Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis.RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients.Prognostic value of preoperative Ca125 and Tag72 serum levels and their correlation to disease relapse and survival in endometrial cancer.Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer.Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study.The role of human epididymis secretory protein E4 in patients with endometrial cancer and premalignant endometrial lesions.Discovery of biomarkers for endometrial cancer: current status and prospects.Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
P2860
Q28067066-ACE3CCDF-704D-4698-980C-CD09504639B3Q34062135-05AB0AF1-EC9D-45FF-8D88-2845E74597DAQ36329414-4E902CA5-6958-40D0-A693-BF250C6F1563Q36372293-9A61AE05-DA93-4761-B883-70127C970F98Q37473123-6963BCB6-CAB1-4683-BB97-7E7EF8CD198FQ38234228-AA6D5F47-206E-4498-8B13-F36C108033BFQ38958066-12539A5D-4F24-4D0F-AA85-8F781594D94AQ40056725-8ACFF2F2-7E88-47FB-B21C-AF7146FB44BDQ43506716-DE4984DE-4C7D-4957-8E1A-8A2D1D72BD2EQ47134921-C379DB94-D17E-493C-B0DE-932D42963766Q47644020-C10B0AAE-1C84-4AEE-8DD6-D0E9925647B8Q51242071-3EEB2C2E-C9EA-4293-B86E-BF17970A551CQ51341963-4A753D81-44D2-4C28-87D5-44B4322B49E0Q54993659-0F01E9B1-24AE-475B-955C-61747C3D325AQ57903637-EF3FC887-5556-4198-A7DB-3D786D0F561B
P2860
HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
HE4 and CA125 levels in the pr ...... e multicenter study (ENDOMET).
@en
HE4 and CA125 levels in the pr ...... prospective multicenter study
@nl
type
label
HE4 and CA125 levels in the pr ...... e multicenter study (ENDOMET).
@en
HE4 and CA125 levels in the pr ...... prospective multicenter study
@nl
prefLabel
HE4 and CA125 levels in the pr ...... e multicenter study (ENDOMET).
@en
HE4 and CA125 levels in the pr ...... prospective multicenter study
@nl
P2093
P2860
P3181
P356
P1476
HE4 and CA125 levels in the pr ...... e multicenter study (ENDOMET).
@en
P2093
Annika Loft Jakobsen
Carsten L Fagö-Olsen
Claus Høgdall
Erik S Andersen
Estrid Høgdall
Ib J Christensen
Kirsten Jochumsen
Magnus Lydolph
Sofie L Antonsen
P2860
P304
P356
10.1111/AOGS.12235
P50
P577
2013-11-01T00:00:00Z